Voices
Arndt Vogel: Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer
Arndt Vogel/aasld.org

Arndt Vogel: Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer

Arndt Vogel, Head of the Center for Personalized Medicine, MHH at Medical University of Hanover, shared on X:

“Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer.

Low-dose aspirin resulted in a significantly lower risk of recurrence with hotspot mutations. Similar benefit with other alterations in PI3K pathway

I would take it…”

Title: Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer

Authors: Anna Martling, Ida Hed Myrberg, Mef Nilbert, Henrik Grönberg, Fredrik Granath, Martin Eklund, Tom Öresland, Lene H. Iversen, Carola Haapamäki, Martin Janson, Karin Westberg, Josefin Segelman, Urban Ersson, Mattias Prytz, Eva Angenete, Rebecka Bergström, Markus Mayrhofer, Bengt Glimelius, Johan Lindberg

Read The Full Article NEJM.

More posts featuring Arndt Vogel.

Anna Martling Arndt Vogel Bengt Glimelius cancer Carola Haapamäki colorectal cancer Eva Angenete Fredrik Granath GI oncology Henrik Grönberg Ida Hed Myrberg Johan Lindberg Josefin Segelman Karin Westberg Lene H. Iversen Markus Mayrhofer Martin Eklund Martin Janson Mattias Prytz Mef Nilbert OncoDaily Oncology Rebecka Bergström Tom Öresland Urban Ersson